LIVE · 41 SOURCES
Search stories, MPs, sources
News
Latest news Full archive Activity log Weather Blindspot Divergence Clusters
Politics
Political parties MPs, Senate & ridings Municipal Lobbying Appointments Ethics tracker Officers
Elections
Election calendar Candidates & races Ridings directory Candidate search Party records Federal Provincial Municipal Coverage readiness Ridings
Money
Economy Bank of Canada rates Cost of Parliament Global Affairs spending Debt tracker Where the money goes Markets
Media
Sources Owners Journalists CRTC Echo — slogans & phrases
Data
Coverage map Accountability chain Cross-Watch Claims Developer API Education API Search everything
About
Methodology The newsroom Governance & ethics C.R.E.E.D. Media literacy Score an article Subscribe to What The Fact Sign in →
← Back to News
The Conversation Canada 📰 The Conversation (academic) Sep 8, 2026 · 5 min read AI Analyzed ○ Unverifiable View full audit trail → C.R.E.E.D. audited

We designed a new way to build miniature fluidic devices to enable personalized cancer treatment

Original article ↗
B.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3) 0.00 · CENTER
ML v2 (DistilBERT) 0.245 · RIGHT
Ensemble 0.245 · CENTER
🏦 Source Intelligence
📰 Media · The Conversation (academic)
CA
Rolling outlet bias
CENTER LEFT
avg -0.351
from 82 scored articles · last 30d
469 articles tracked all-time
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
🔍 Intelligence Feed
    Cross-Watch · Gov · Parliament · Legal · Civic
    📄 Related Gov Tenders
      Via Gov Watch · CanadaBuys + PSPC tenders
      🏛 Related Parliament Votes
        Via Civic Watch · OpenParliament.ca
        🔗 Cross-Watch
        Named in this story — also tracked across the Watch Series.
        🏙 Related Municipal Events
          Via Civic Watch · City council, bylaws & permits
          Article Excerpt
          Researchers Sara Hassanpour Tamrin (left) and Arindom Sen (right) discuss the pattern of tiny channels used in their new method for making microfluidic devices. (Joe McFarland/University of Calgary) We designed a new way to build miniature fluidic devices to enable personalized cancer treatment Published: September 8, 2026 3.57pm EDT Share article Print article There is no “one-size-fits-all” treatment for patients living with cancer. Cancer occurs when normal cells in the body genetically mutate and transform into abnormal cells that divide uncontrollably. In most cases, these cancer cells form a solid mass of tissue called a tumour. The genetic changes that cause a tumour can influence its composition, so two people may have the same type of cancer but different types of tumours. A treatment may then work for one patient but not another. Tumour-on-a-chip technology enables us to recreate features of an individual patient’s tumour outside the body and test different treatments. The chips are biomedical devices small enough to fit into the palm of a hand. They contain tiny channels, called microfluidic systems, through which nutrient-rich fluids can flow to support tumour growth. The technology is promising but difficult and expensive to manufacture. We have developed a simple, cost-effective way to build chips containing microfluidic systems, with the goal of making the technology more accessible. We are also now exploring the use of this technology for childhood brain cancer. Miniature (microfluidic) devices created using our simplified fabrication method. (Joe McFarland/University of Calgary) Creating tumours outside the body Treatments that work well in the laboratory are not always effective in patients. One reason is that tumours recreated in laboratory dishes typically do not include the complex tumour environment found inside the body. In the body, tumour cells interact with cells and signals from their surroundings, which can alter how they behave and respond to a treatment. The ability to sample cancer cells from a patient and grow the tumour within a complex environment outside the body could help doctors safely and efficiently test a wide range of personalized treatment options for that patient. This would help avoid ineffective treatments and save time in finding the right approach. A tumour-on-a-chip recreates key features of a patient’s tumour in a miniature device. Figure created in part with BioRender.com. (Sara Hassanpour…
          Read full article at The Conversation Canada ↗
          How we scored this article

          WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.

          Full audit trail for this article →

          Cite this analysis